Cynata Therapeutics Limited (CYYNF)

Cynata Therapeutics Limited (CYYNF) Financial Statements


Cynata Therapeutics Limited Financial Overview

Cynata Therapeutics Limited's market cap is currently ―. The company's EPS TTM is $-0.058; its P/E ratio is -1.88; Cynata Therapeutics Limited is scheduled to report earnings on August 22, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement-
Total Revenue-----
Gross Profit-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 23.80MAU$ 26.72MAU$ 13.65MAU$ 6.98MAU$ 12.21M
Total AssetsAU$ 26.55MAU$ 29.97MAU$ 17.48MAU$ 12.25MAU$ 16.13M
Total DebtAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -23.80MAU$ -26.72MAU$ -13.65MAU$ -6.98MAU$ -12.21M
Total LiabilitiesAU$ 2.59MAU$ 1.60MAU$ 689.74KAU$ 1.28MAU$ 746.15K
Stockholders EquityAU$ 23.96MAU$ 28.37MAU$ 16.79MAU$ 10.97MAU$ 15.39M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Cynata Therapeutics Limited Earnings and Revenue History

Cynata Therapeutics Limited Debt to Assets

Cynata Therapeutics Limited Cash Flow

Cynata Therapeutics Limited Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis